Magrolimab plus Azacitidine Versus Azacitidine plus Placebo in Untreated Higher Risk Myelodysplastic Syndrome: The Phase 3, Randomized, ENHANCE Study
2021
-
Correction
-
Source
-
Cite
-
Save
0
References
0
Citations
NaN
KQI